JDRF Announces Diabetes Research Program with Johnson & Johnson
The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to...
View ArticleClik here to view.
Diamyd and Ortho-McNeil-Janssen Pharmaceuticals Agreement Receives Antitrust...
Diamyd Medical AB announced it has received antitrust clearance that closes the transaction announced on June 22, 2010 with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson...
View ArticleClik here to view.
LifeScan Recalls OneTouch VerioIQ Blood Glucose Meters
Johnson & Johnson’s LifeScan, Inc. is initiating a voluntary recall and replacement for all of its OneTouch VerioIQ blood glucose meters in the United States, effective immediately. LifeScan is...
View ArticleClik here to view.
FDA Approves Janssen’s Invokana, the First in a New Class of Type 2 Diabetes...
The FDA has approved Janssen Pharmaceutical’s new type 2 diabetes treatment, Invokana (canagliflozin). Invokana is the first in a new class of medications called sodium glucose co-transporter 2...
View ArticleClik here to view.
How Invokana Works: New Type 2 Diabetes Drug Hailed as a Major Treatment Advance
Approval of Invokana, new kind of type 2 diabetes drug, by the U.S. Food and Drug Administration means diabetics have a significant new tool for treating the disease, as well as for losing weight and...
View ArticleJDRF Announces Diabetes Research Program with Johnson & Johnson
The Juvenile Diabetes Research Foundation announced today in a press release that it will begin working with The Johnson & Johnson Corporate Office of Science and Technology, and its affiliates, to...
View ArticleClik here to view.
Diamyd and Ortho-McNeil-Janssen Pharmaceuticals Agreement Receives Antitrust...
Diamyd Medical AB announced it has received antitrust clearance that closes the transaction announced on June 22, 2010 with Ortho-McNeil-Janssen Pharmaceuticals, Inc. (OMJPI), a Johnson & Johnson...
View Article
